These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 36706951)

  • 1. Structure and Content of a Taxonomy to Support the Use of Real-World Evidence by Health Technology Assessment Practitioners and Healthcare Decision Makers.
    Murphy LA; Akehurst R; Solà-Morales O; Cunningham D; Mestre-Ferrandiz J; Franklin M; de Pouvourville G
    Value Health; 2023 Apr; 26(4S):20-31. PubMed ID: 36706951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Real-World Evidence Workstream in EUreccA 2025: How the Task Was Addressed.
    Murphy LA; Akehurst R; Solà-Morales O; Cunningham D; Mestre-Ferrandiz J; Franklin M; de Pouvourville G
    Value Health; 2023 Apr; 26(4S):43-51. PubMed ID: 36642216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Using Real-World Data in the Health Technology Assessment of Pharmaceuticals: Strengths, Difficulties, and a Pragmatic Way Forward.
    Akehurst R; Murphy LA; Solà-Morales O; Cunningham D; Mestre-Ferrandiz J; de Pouvourville G
    Value Health; 2023 Apr; 26(4S):11-19. PubMed ID: 36706952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can we use existing guidance to support the development of robust real-world evidence for health technology assessment/payer decision-making?
    Capkun G; Corry S; Dowling O; Asad Zadeh Vosta Kolaei F; Takyar S; Furtado C; Jónsson P; Kleinermans D; Lambert L; Schiel A; Facey K
    Int J Technol Assess Health Care; 2022 Nov; 38(1):e79. PubMed ID: 36321447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The challenges and opportunities in using real-world data to drive advances in healthcare in East Asia: expert panel recommendations.
    Crane G; Lim JCW; Gau CS; Xie J; Chu L
    Curr Med Res Opin; 2022 Sep; 38(9):1543-1551. PubMed ID: 35786170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Data Governance for Real-World Data Management: A Proposal for a Checklist to Support Decision Making.
    Solà-Morales O; Sigurðardóttir K; Akehurst R; Murphy LA; Mestre-Ferrandiz J; Cunningham D; de Pouvourville G
    Value Health; 2023 Apr; 26(4S):32-42. PubMed ID: 36870678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Value based healthcare and Health Technology Assessment for emerging market countries: joint efforts to overcome barriers.
    Otte M; Dauben HP; Ahn J; Gutierrez Ibarluzea I; Drummond M; Simoens S; Kaló Z; Suh DC
    Expert Rev Pharmacoecon Outcomes Res; 2024 Nov; 24(9):1061-1066. PubMed ID: 39221874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Meta-analyses using real-world data to generate clinical and epidemiological evidence: a systematic literature review of existing recommendations.
    Briere JB; Bowrin K; Taieb V; Millier A; Toumi M; Coleman C
    Curr Med Res Opin; 2018 Dec; 34(12):2125-2130. PubMed ID: 30217138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Real-world data for health technology assessment for reimbursement decisions in Asia: current landscape and a way forward.
    Lou J; Kc S; Toh KY; Dabak S; Adler A; Ahn J; Bayani DBS; Chan K; Choiphel D; Chua B; Genuino AJ; Guerrero AM; Kearney B; Lin LW; Liu Y; Nakamura R; Pearce F; Prinja S; Pwu RF; Shafie AA; Sui B; Suwantika A; Teerawattananon Y; Tunis S; Wu HM; Zalcberg J; Zhao K; Isaranuwatchai W; Wee HL
    Int J Technol Assess Health Care; 2020 Oct; 36(5):474-480. PubMed ID: 32928330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Avoiding and identifying errors in health technology assessment models: qualitative study and methodological review.
    Chilcott J; Tappenden P; Rawdin A; Johnson M; Kaltenthaler E; Paisley S; Papaioannou D; Shippam A
    Health Technol Assess; 2010 May; 14(25):iii-iv, ix-xii, 1-107. PubMed ID: 20501062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measuring the Effectiveness of Real-World Evidence to Ensure Appropriate Impact.
    Brown JP; Douglas IJ; Hanif S; Thwaites RMA; Bate A
    Value Health; 2021 Sep; 24(9):1241-1244. PubMed ID: 34452702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improving transparency to build trust in real-world secondary data studies for hypothesis testing-Why, what, and how: recommendations and a road map from the real-world evidence transparency initiative.
    Orsini LS; Monz B; Mullins CD; Van Brunt D; Daniel G; Eichler HG; Graff J; Guerino J; Berger M; Lederer NM; Jonsson P; Schneeweiss S; Wang SV; Crown W; Goettsch W; Willke RJ
    Pharmacoepidemiol Drug Saf; 2020 Nov; 29(11):1504-1513. PubMed ID: 32924243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improving Transparency to Build Trust in Real-World Secondary Data Studies for Hypothesis Testing-Why, What, and How: Recommendations and a Road Map from the Real-World Evidence Transparency Initiative.
    Orsini LS; Berger M; Crown W; Daniel G; Eichler HG; Goettsch W; Graff J; Guerino J; Jonsson P; Lederer NM; Monz B; Mullins CD; Schneeweiss S; Brunt DV; Wang SV; Willke RJ
    Value Health; 2020 Sep; 23(9):1128-1136. PubMed ID: 32940229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integration of real-world evidence from different data sources in health technology assessment.
    Graili P; Guertin JR; Chan KKW; Tadrous M
    J Pharm Pharm Sci; 2023; 26():11460. PubMed ID: 37529633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Study types and reliability of Real World Evidence compared with experimental evidence used in Polish reimbursement decision-making processes.
    Wilk N; Wierzbicka N; Skrzekowska-Baran I; Moćko P; Tomassy J; Kloc K
    Public Health; 2017 Apr; 145():51-58. PubMed ID: 28359391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Real-world evidence: perspectives on challenges, value, and alignment of regulatory and national health technology assessment data collection requirements.
    Sievers H; Joos A; Hiligsmann M
    Int J Technol Assess Health Care; 2021 Feb; 37():e40. PubMed ID: 33622423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Guidance on using real-world evidence from Western Europe in Central and Eastern European health policy decision making.
    Németh B; Kamusheva M; Mitkova Z; Petykó ZI; Zemplényi A; Dimitrova M; Tachkov K; Balkányi L; Czech M; Dawoud D; Goettsch W; Hren R; Knies S; Lorenzovici L; Maravic Z; Piniazhko O; Zerovnik S; Kaló Z
    J Comp Eff Res; 2023 Apr; 12(4):e220157. PubMed ID: 36861458
    [No Abstract]   [Full Text] [Related]  

  • 18. Developing a framework to incorporate real-world evidence in cancer drug funding decisions: the Canadian Real-world Evidence for Value of Cancer Drugs (CanREValue) collaboration.
    Chan K; Nam S; Evans B; de Oliveira C; Chambers A; Gavura S; Hoch J; Mercer RE; Dai WF; Beca J; Tadrous M; Isaranuwatchai W
    BMJ Open; 2020 Jan; 10(1):e032884. PubMed ID: 31915169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of Multi-Criteria Decision Analysis (MCDA) to Prioritize Real-World Evidence Studies for Health Technology Management: Outcomes and Lessons Learned by the Canadian Real-World Evidence for Value of Cancer Drugs (CanREValue) Collaboration.
    Takhar P; Geirnaert M; Gavura S; Beca J; Mercer RE; Denburg A; Muñoz C; Tadrous M; Parmar A; Dionne F; Boehm D; Chambers C; Craig E; Trudeau M; Cheung MC; Houlihan J; McDonald V; Pechlivanoglou P; Taylor M; Wasylenko E; Wranik WD; Chan KKW
    Curr Oncol; 2024 Apr; 31(4):1876-1898. PubMed ID: 38668044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of Real-World Evidence for Regulatory Approval and Coverage of Medical Devices: A Landscape Assessment.
    Timbie JW; Kim AY; Concannon TW
    Value Health; 2021 Dec; 24(12):1792-1798. PubMed ID: 34838277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.